These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 25725942)

  • 1. A noninflammatory immune response in aged DNA Aβ42-immunized mice supports its safety for possible use as immunotherapy in AD patients.
    Lambracht-Washington D; Rosenberg RN
    Neurobiol Aging; 2015 Mar; 36(3):1274-81. PubMed ID: 25725942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a DNA Aβ42 Vaccine in Aged NZW Rabbits: Antibody Kinetics and Immune Profile after Intradermal Immunization with Full-Length DNA Aβ42 Trimer.
    Lambracht-Washington D; Fu M; Wight-Carter M; Riegel M; Rosenberg RN
    J Alzheimers Dis; 2017; 57(1):97-112. PubMed ID: 28222511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a DNA Aβ42 vaccine in adult rhesus monkeys (Macaca mulatta): antibody kinetics and immune profile after intradermal immunization with full-length DNA Aβ42 trimer.
    Lambracht-Washington D; Fu M; Frost P; Rosenberg RN
    Alzheimers Res Ther; 2017 Apr; 9(1):30. PubMed ID: 28441965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active full-length DNA Aβ
    Rosenberg RN; Fu M; Lambracht-Washington D
    Alzheimers Res Ther; 2018 Nov; 10(1):115. PubMed ID: 30454039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA beta-amyloid(1-42) trimer immunization for Alzheimer disease in a wild-type mouse model.
    Lambracht-Washington D; Qu BX; Fu M; Eagar TN; Stüve O; Rosenberg RN
    JAMA; 2009 Oct; 302(16):1796-802. PubMed ID: 19861672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-stimulation with TNF receptor superfamily 4/25 antibodies enhances in-vivo expansion of CD4+CD25+Foxp3+ T cells (Tregs) in a mouse study for active DNA Aβ42 immunotherapy.
    Lambracht-Washington D; Rosenberg RN
    J Neuroimmunol; 2015 Jan; 278():90-9. PubMed ID: 25595257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA immunization against amyloid beta 42 has high potential as safe therapy for Alzheimer's disease as it diminishes antigen-specific Th1 and Th17 cell proliferation.
    Lambracht-Washington D; Qu BX; Fu M; Anderson LD; Stüve O; Eagar TN; Rosenberg RN
    Cell Mol Neurobiol; 2011 Aug; 31(6):867-74. PubMed ID: 21625960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancing Th2 immune responses against amyloid protein by a DNA prime-adenovirus boost regimen for Alzheimer's disease.
    Kim HD; Jin JJ; Maxwell JA; Fukuchi K
    Immunol Lett; 2007 Sep; 112(1):30-8. PubMed ID: 17686533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A peptide prime-DNA boost immunization protocol provides significant benefits as a new generation Aβ42 DNA vaccine for Alzheimer disease.
    Lambracht-Washington D; Qu BX; Fu M; Anderson LD; Eagar TN; Stüve O; Rosenberg RN
    J Neuroimmunol; 2013 Jan; 254(1-2):63-8. PubMed ID: 23036592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-immunization with DNA and protein mixture: a safe and efficacious immunotherapeutic strategy for Alzheimer's disease in PDAPP mice.
    Liu S; Shi D; Wang HC; Yu YZ; Xu Q; Sun ZW
    Sci Rep; 2015 Jan; 5():7771. PubMed ID: 25586780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strikingly reduced amyloid burden and improved behavioral performance in Alzheimer's disease mice immunized with recombinant chimeric vaccines by hexavalent foldable Aβ₁₋₁₅ fused to toxin-derived carrier proteins.
    Yu YZ; Wang WB; Chen A; Chang Q; Liu S; Zhao M; Wang S; Qiu WY; Pang XB; Xu Q; Sun ZW
    J Alzheimers Dis; 2014; 41(1):243-60. PubMed ID: 24625800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abeta42 gene vaccine prevents Abeta42 deposition in brain of double transgenic mice.
    Qu BX; Xiang Q; Li L; Johnston SA; Hynan LS; Rosenberg RN
    J Neurol Sci; 2007 Sep; 260(1-2):204-13. PubMed ID: 17574274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in the brain transcriptome after DNA Aβ42 trimer immunization in a 3xTg-AD mouse model.
    Lambracht-Washington D; Fu M; Hynan LS; Rosenberg RN
    Neurobiol Dis; 2021 Jan; 148():105221. PubMed ID: 33316368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripherally administered sera antibodies recognizing amyloid-β oligomers mitigate Alzheimer's disease-like pathology and cognitive decline in aged 3× Tg-AD mice.
    Wang HC; Yu YZ; Liu S; Zhao M; Xu Q
    Vaccine; 2016 Apr; 34(15):1758-66. PubMed ID: 26945100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Aβ42 gene vaccine for prevention and treatment of Alzheimer's disease].
    Rosenberg RN
    Rinsho Shinkeigaku; 2010 Nov; 50(11):838. PubMed ID: 21921464
    [No Abstract]   [Full Text] [Related]  

  • 16. Passive immunization of the Abeta42(43) C-terminal-specific antibody BC05 in a mouse model of Alzheimer's disease.
    Asami-Odaka A; Obayashi-Adachi Y; Matsumoto Y; Takahashi H; Fukumoto H; Horiguchi T; Suzuki N; Shoji M
    Neurodegener Dis; 2005; 2(1):36-43. PubMed ID: 16909001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective DNA epitope chimeric vaccines for Alzheimer's disease using a toxin-derived carrier protein as a molecular adjuvant.
    Yu YZ; Wang S; Bai JY; Zhao M; Chen A; Wang WB; Chang Q; Liu S; Qiu WY; Pang XB; Xu Q; Sun ZW
    Clin Immunol; 2013 Oct; 149(1):11-24. PubMed ID: 23886550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined treatment of amyloid-β₁₋₄₂-stimulated bone marrow-derived dendritic cells plus splenocytes from young mice prevents the development of Alzheimer's disease in APPswe/PSENldE9 mice.
    Wang F; Liu H; Shen X; Ao H; Moore N; Gao L; Chen L; Hu H; Ma H; Yang Z; Zhai C; Qin J; Zhou G; Peng Y; Feng X; Li R; Liang C
    Neurobiol Aging; 2015 Jan; 36(1):111-22. PubMed ID: 25085784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA Aβ42 immunization via needle-less Jet injection in mice and rabbits as potential immunotherapy for Alzheimer's disease.
    Lambracht-Washington D; Fu M; Wight-Carter M; Riegel M; Hynan LS; Rosenberg RN
    J Neurol Sci; 2023 Mar; 446():120564. PubMed ID: 36731358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-Abeta42- and anti-Abeta40-specific mAbs attenuate amyloid deposition in an Alzheimer disease mouse model.
    Levites Y; Das P; Price RW; Rochette MJ; Kostura LA; McGowan EM; Murphy MP; Golde TE
    J Clin Invest; 2006 Jan; 116(1):193-201. PubMed ID: 16341263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.